Ovarian cancer differential diagnosis: Difference between revisions

	Ovarian cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classifications
Pathophysiology
Causes of Ovarian cancer
Differentiating Ovarian cancer from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms
Physical Examination
Staging
Laboratory Findings
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ovarian cancer differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ovarian cancer differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ovarian cancer differential diagnosis
CDC on Ovarian cancer differential diagnosis
Ovarian cancer differential diagnosis in the news
Blogs on Ovarian cancer differential diagnosis
Directions to Hospitals Treating Ovarian cancer
Risk calculators and risk factors for Ovarian cancer differential diagnosis

VisualWikitext

Revision as of 17:33, 24 January 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Differentiating [Disease name] from other Diseases

				Symptoms			Physical examination			Lab Findings	Imaging		Immunohistopathology
Diseases		Clinical manifestations								Para-clinical findings				Gold standard	Additional findings
		Specific risk factors	Age of onset	Symptoms			Physical examination			Para-clinical findings
				pelvic pain or pressure	vaginal discharge	GI dysturbance	Pleural effusion	Fever	Tendernes	Lab Findings	CT scan	MRI	Immunohistopathology
Gynecologic
Ovarian	Follicular or corpus luteum cysts
	Serous cystadenoma/carcinoma
	Mucinous cystadenoma/carcinoma
	Endometrioma														infertility
	Teratoma
	Dysgerminoma
	Choriocarcinoma
	Yolk sac tumor
	Fibroma
	Thecoma
	Granulosa cell tumor
	Sertoli-lydig cell tumor
	Brenner tumor
	Metastasis (krukenberg)
Tubal	tubo-ovarian abscess														fever and vaginal discharge
	Ectopic pregnancy
	Hydrosalpinx														infertility
	Tuberculosis salpingitis
	Epithelial carcinoma
	serous tubal intraepithelial neoplasm
Uterine	Myoma
	Sarcoma
	Pregnancy
Non-gynecologic
GIT	Apppendiceal abscess
	Appendiceal neoplasm
	Diverticular abscess
	GI neoplasm														abdominal pain Intestinal obstruction and bleeding in small bowel,
Renal	Pelvic kidney														tract infection (UTI), obstruction, and renal calculi.
Others	Retroperitoneal sarcoma														Gastrointestinal symptoms, such as early satiety, obstruction,lower extremity edema, Serous ascites

check sites of cancer that may metastasize to the ovaries (eg, stomach, colorectal, breast)

check rectum, liver, spleen, lungs, inguinal or supraclavicular lymph nodes for ovary metastase

References

Template:WH Template:WS

@@ Line 10: / Line 10: @@
 |- style="background: #4479BA; color: #FFFFFF; text-align: center;"
 ! colspan="2" rowspan="4" |Diseases
-| colspan="9" |'''Clinical manifestations'''
+| colspan="8" |'''Clinical manifestations'''
 ! colspan="4" rowspan="2" |Para-clinical findings
 | colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
@@ Line 17: / Line 17: @@
 | rowspan="3" |Specific risk factors
 | rowspan="3" |Age of onset
-| colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
+| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
 ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
 |-
@@ Line 27: / Line 27: @@
 ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |vaginal discharge
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI dysturbance
-!'''Constitutional'''
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Pleural effusion'''
-! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 2
+! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Fever'''
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam 3
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Tendernes
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI
 |-
-! colspan="17" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Gynecologic
+! colspan="16" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Gynecologic
 |-
 | rowspan="14" |Ovarian
 |Follicular or corpus luteum cysts
-|
 |
 |
@@ Line 60: / Line 58: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 77: / Line 74: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 94: / Line 90: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 111: / Line 106: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 128: / Line 122: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 145: / Line 138: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 162: / Line 154: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 179: / Line 170: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 196: / Line 186: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 213: / Line 202: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 230: / Line 218: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 247: / Line 234: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 264: / Line 250: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 277: / Line 262: @@
 | rowspan="6" |Tubal
 |tubo-ovarian abscess
-|
 |
 |
@@ Line 299: / Line 283: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 316: / Line 299: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 333: / Line 315: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 350: / Line 331: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 367: / Line 347: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 385: / Line 364: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 402: / Line 380: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 419: / Line 396: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 430: / Line 406: @@
 | style="background: #F5F5F5; padding: 5px;" |
 |-
-! colspan="17" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Non-gynecologic
+! colspan="16" style="background: #7d7d7d; color: #FFFFFF; text-align: center;" |Non-gynecologic
 |-
 | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |GIT
@@ Line 439: / Line 415: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 456: / Line 431: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 473: / Line 447: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 490: / Line 463: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 508: / Line 480: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 526: / Line 497: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |

Ovarian cancer differential diagnosis: Difference between revisions

Revision as of 17:33, 24 January 2019

Overview

Differentiating [Disease name] from other Diseases

References

Navigation menu